Clinical Trials Directory

Trials / Completed

CompletedNCT01415388

Study to Investigate the Effects of Krill Oil on Fasting Serum Triglycerides

A Double-blind, Randomized, Multi-centre, Placebo-controlled Study to Investigate the Effects of Superba(TM) Krill Oil on Fasting Serum Triglycerides

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
300 (actual)
Sponsor
Aker BioMarine Human Ingredients AS · Industry
Sex
All
Age
21 Years – 79 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to assess the effect of 12 weeks of daily supplementation with Superba(TM) Krill Oil on fasting serum triglyceride levels and omega-3 index in subjects whose habitual fatty fish and seafood intake is low and who have borderline high or high fasting serum triglyceride levels.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTKrill Oil4 Capsules twice daily providing 0 (placebo), 0.5, 1.0, 2.0, or 4.0 g krill oil/day for a period of 12 weeks

Timeline

Start date
2011-08-01
Primary completion
2012-09-01
Completion
2012-09-01
First posted
2011-08-12
Last updated
2013-02-21

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01415388. Inclusion in this directory is not an endorsement.

Study to Investigate the Effects of Krill Oil on Fasting Serum Triglycerides (NCT01415388) · Clinical Trials Directory